Navigation Links
RTX Healthcare Launch Wireless Telehealth Monitor With Built-in GSM/GPRS Mobile Phone Technology
Date:5/19/2008

Remote Monitoring of Elderly People Suffering From CHF, COPD, Diabetes and Other Chronic Diseases now Becomes Easier and More Effective With a New Interactive Telehealth Monitor Based on GSM/GPRS Mobile Phone Technology

NOERRESUNDBY, Denmark, May 19 /PRNewswire-FirstCall/ -- RTX Healthcare today announced a new member to the family of interactive telehealth monitors, which allows healthcare system integrators and disease management companies to effectively monitor patients at home. The RTX3371 GSM/GPRS Telehealth Monitor collects vital signs wirelessly from external devices and subjective patient information from patient questionnaires and transmits the data directly to the system integrator or disease management company's own clinical information system. The collected vital signs include weight, blood pressure, blood glucose, peak flow, SpO2, ECG, blood coagulation and others. All external devices are products from major third party medical device manufacturers.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080519/305351 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20080219/293533-a )

Bjarne Flou, CEO of RTX Healthcare says: "Expanding our product portfolio to include a GSM/GPRS mobile phone technology enabled Telehealth Monitor is a natural next step in the progression of our vision to become the preferred supplier of telehealth equipment. Our Telehealth Monitors are extremely simple and intuitive to use for elderly patients. Furthermore, the flexibility of the device and our business model, where RTX Healthcare sell the RTX3371 Telehealth Monitor for a one-off fee without a proprietary backend, makes our monitors an easy and preferred choice for telehealth providers". Bjarne Flou continues: "The RTX3371 GSM/GPRS Telehealth Monitor is the second member of a family of telehealth monitors, which also include the RTX3370 monitor with built-in PSTN landline phone modem".

About RTX Healthcare A/S

RTX Healthcare focuses entirely on helping people suffering from chronic diseases to live a better and longer life with their disease. RTX Healthcare specializes in the development and manufacturing of wireless medical devices for remote monitoring. It is RTX Healthcare's vision to be known and recognized as a market leader in the healthcare industry at delivering the most appropriate and cost-effective telehealth solutions. RTX Healthcare is a subsidiary company of RTX Telecom A/S, which is based in Denmark with offices in California and Hong Kong. RTX Telecom A/S is listed on the Nordic Stock Exchange, Copenhagen (OMX). For further information, please visit: http://www.rtx.dk.

RTX Healthcare media contact:

Europe, Bjarne Flou, CEO,

Tel.: +45-9632-2300,

E-mail: bf@rtx.dk. USA,

Anthony Taroni,

Sales Director,

Tel.: +1-(408)-441-8600,

E-mail: ata@rtxamerica.com


'/>"/>
SOURCE RTX Healthcare A/S
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
2. The German Embassy Would Like to Draw Your Attention to the Press Release of the University of Minnesota Center for German & European Studies to Present Major Healthcare Forum
3. Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008
4. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference
6. Dont Wait for the Election to Plan Your Long-Term Healthcare, Insurance Leader Advises
7. Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement
8. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
9. IADR and GlaxoSmithKline Consumer Healthcare announce winners
10. BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
11. Gerson Lehrman Group and iGuard, Inc. Partner to Offer Patients a Voice in Healthcare Industry Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: